Skip to content

Magnetic Resonance Imaging (MRI) Sequences Optimization in Healthy Subjects

MRI Sequences Optimization in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02900339
Acronym
OSS-IRM
Enrollment
628
Registered
2016-09-14
Start date
2013-04-18
Completion date
2021-10-12
Last updated
2022-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

MRI, Sequence optimization, Healthy volunteers

Brief summary

Magnetic resonance imaging (MRI) is a noninvasive and non-ionizing (no use of X-rays) imaging modality. Today it is considered an anatomical and functional exploration reference technique. Since its inception around 1985, this technology is constantly evolving. Many advances in MRI require constant adaptations of radiological practices. The morphological image is now associated with functional and parametric information (infusion, diffusion spectroscopy, etc ...). In parallel, work combining acquisition and post-processing of data also open new applications (tractography, functional MRI, etc ....). Thus, more and more procedures are necessary to integrate these techniques for the diagnosis and adapt to new demands of clinicians. The type of sequence and its associated parameters allow to directly influence the contrast of images, to characterize tissue compared to another and, ultimately, to highlight morphological or functional abnormality. Image quality can be optimized on each MRI, depending on the time available for the acquisition on the one hand, and on the desired resolution and contrast, on the other hand. For each sequence, it is therefore necessary to find a compromise that will optimize the diagnostic quality of the examination. This optimization requires a phase focusing on healthy volunteers. It is therefore important that researchers and physicists could design on healthy volunteers, the best settings of all parameters for an image or spectrum. Indeed, it is always necessary to properly optimize every parameter choices before beginning a study of a cohort of patients. In this context, the main objective of this study is to optimize sequences and imaging protocols to evaluate and validate the choice of parameters in healthy volunteers.

Interventions

DEVICEMagnetic Resonance Imaging

MRI of the Neurinfo platform is an MRI 3 Tesla Magnetom Verio model, Siemens (Siemens Healthcare, Erlangen, Germany). This imager is marked for European Conformity (CE), ensuring compliance with European Union safety standards.

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men or women aged over 18 years * Written informed consent given

Exclusion criteria

* contraindication to MRI : * Claustrophobia * morphotype not allowing access to MRI * Wear a metallic implant, such as: * Pacemaker (pacemaker) * Ferromagnetic surgical clips * Intra orbital metallic foreign bodies or encephalic * Pregnancy * Breastfeeding * Adults under guardianship, trusteeship or safeguard justice * No social Insurance

Design outcomes

Primary

MeasureTime frameDescription
Quantitative assessment of acquired sequencesOne day after data acquisitionsQuality images, maps or spectra acquired with optimized parameters will be compared to standard acquisitions. This evaluation will be based on quantitative criteria extracted from computer analysis of the data : signal to noise ratio, contrast-to-noise, blur level, information sharing, collocation of areas set evidenced by the different techniques, etc...

Secondary

MeasureTime frameDescription
Qualitative assessment of acquired sequencesOne day after data acquisitionsQuality images, maps or spectra acquired with optimized parameters will be compared to standard acquisitions. This evaluation will be based on statistical comparison of visual qualitative criteria by experts radiologists

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026